Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Genetically Engineered Animals
Knockout Mice
Knockout Rats
Knockin Mice
Knockin Rats
Transgenic Mice
Transgenic Rats
Model Generation Techniques
Turboknockout<sup>®</sup> Gene Targeting
ES Cell Gene Targeting
Targeted Gene Editing
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Research Models
HUGO-GT™ Humanized Mice
Cre Mouse Lines
Humanized Target Gene Models
Metabolic Disease Models
Ophthalmic Disease Models
Neurological Disease Models
Autoimmune Disease Models
Immunodeficient Mouse Models
Humanized Immune System Mouse Models
Oncology & Immuno-oncology Models
Covid-19 Mouse Models
MouseAtlas Model Library
Knockout Cell Line Product Catalog
Tumor Cell Line Product Catalog
AAV Standard Product Catalog
Animal Supporting Services
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
BAC Modification
Custom Cell Line Models
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Point Mutation Cell Lines
Overexpression Cell Lines
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Lentivirus Packaging
Adenovirus Packaging
CRO Services
By Therapeutic Area
Oncology
Ophthalmology
Neuroscience
Metabolic & Cardiovascular Diseases
Autoimmune & Inflammatory
By Drug Type
AI-Powered AAV Discovery
Gene Therapy
Oligonucleotide Therapy
Antibody Therapy
Cell Immunotherapy
Resources
Promotion
Events & Webinars
Newsroom
Blogs & Insights
Resource Vault
Reference Databases
Peer-Reviewed Citations
Rare Disease Data Center
AbSeek
Cell iGeneEditor™ System
OriCell
Quality
Facility Overview
Animal Health & Welfare
Health Reports
About Us
Corporate Overview
Our Partners
Careers
Contact Us
Login
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
Organization
Job Role
Country
Catalog Type
Product Name
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
C57BL/6NCya-Prknem1/Cya
Common Name:
Prkn-KO
Product ID:
S-KO-10233
Background:
C57BL/6NCya
Product Type
Age
Genotype
Sex
Quantity
Price:
Contact for Pricing
Basic Information
Strain Name
Prkn-KO
Strain ID
KOCMP-50873-Prkn-B6N-VA
Gene Name
Prkn
Product ID
S-KO-10233
Gene Alias
Park2
Background
C57BL/6NCya
NCBI ID
50873
Modification
Conventional knockout
Chromosome
17
Phenotype
MGI:1355296
Document
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Note
Note: When using this mouse strain in a publication, please cite “C57BL/6NCya-Prknem1/Cya mice (Catalog S-KO-10233) were purchased from Cyagen.”
Strain Description
Ensembl Number
ENSMUST00000191124
NCBI RefSeq
NM_016694
Target Region
Exon 4
Size of Effective Region
~1.3 kb
Detailed Document
Click here to download >>
Overview of Gene Research
Prkn, also known as parkin RBR E3 ubiquitin protein ligase, is crucial for protein ubiquitination and mitophagy, a process of selectively eliminating damaged mitochondria. It functions within the PINK1-Prkn pathway, which is central to mitochondrial quality control. Genetic models, such as gene knockout mouse models, have been instrumental in studying Prkn's functions [1,3,4,5,6,7,8,9].

In a study on COPD pathogenesis, prkn knockout (KO) mice showed enhanced airway wall thickening with emphysematous changes after cigarette smoke exposure, along with damaged mitochondria accumulation, increased oxidative modifications, and accelerated cellular senescence in airway epithelial cells. In vitro, Prkn overexpression could induce mitophagy even with reduced PINK1 levels, while PINK1 overexpression couldn't recover impaired mitophagy from Prkn knockdown, suggesting Prkn is rate-limiting in PINK1-Prkn-mediated mitophagy during cigarette smoke extract exposure [1]. In triple-negative breast cancer, hypoxia-induced GPCPD1 depalmitoylation regulated Prkn-mediated ubiquitination of VDAC1 to trigger mitophagy, promoting tumor growth and metastasis [2]. In colorectal cancer, USP26 interacted with Prkn, facilitating its deubiquitination at K129, reducing its activity and restraining Prkn-mediated mitophagy to drive tumorigenesis [7]. In breast cancer, MANF mediated mitophagy by binding to Prkn in mitochondria under glucose-starvation conditions, promoting cell survival [9].

In summary, Prkn is essential for mitophagy and mitochondrial quality control. Model-based research, especially using Prkn KO mouse models, has revealed its significance in diseases like COPD, triple-negative breast cancer, colorectal cancer, and breast cancer. Understanding Prkn's functions provides insights into disease mechanisms and potential therapeutic targets for these conditions.

References:

1. Araya, Jun, Tsubouchi, Kazuya, Sato, Nahoko, Nakayama, Katsutoshi, Kuwano, Kazuyoshi. 2018. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis. In Autophagy, 15, 510-526. doi:10.1080/15548627.2018.1532259. https://pubmed.ncbi.nlm.nih.gov/30290714/

2. Liu, Ying, Zhang, Hanwen, Liu, Yiwei, Zhang, Ning, Yang, Qifeng. 2023. Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1. In Autophagy, 19, 2443-2463. doi:10.1080/15548627.2023.2182482. https://pubmed.ncbi.nlm.nih.gov/36803235/

3. Clausen, Lene, Okarmus, Justyna, Voutsinos, Vasileios, Lindorff-Larsen, Kresten, Hartmann-Petersen, Rasmus. 2024. PRKN-linked familial Parkinson's disease: cellular and molecular mechanisms of disease-linked variants. In Cellular and molecular life sciences : CMLS, 81, 223. doi:10.1007/s00018-024-05262-8. https://pubmed.ncbi.nlm.nih.gov/38767677/

4. Yan, Chaojun, Gong, Longlong, Chen, Li, Désaubry, Laurent, Song, Zhiyin. 2019. PHB2 (prohibitin 2) promotes PINK1-PRKN/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. In Autophagy, 16, 419-434. doi:10.1080/15548627.2019.1628520. https://pubmed.ncbi.nlm.nih.gov/31177901/

5. Niu, Kaifeng, Fang, Hongbo, Chen, Zixiang, Balajee, Adayabalam S, Zhao, Yongliang. 2019. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy. In Autophagy, 16, 724-734. doi:10.1080/15548627.2019.1656957. https://pubmed.ncbi.nlm.nih.gov/31432739/

6. Yamada, Tatsuya, Dawson, Ted M, Yanagawa, Toru, Iijima, Miho, Sesaki, Hiromi. 2019. SQSTM1/p62 promotes mitochondrial ubiquitination independently of PINK1 and PRKN/parkin in mitophagy. In Autophagy, 15, 2012-2018. doi:10.1080/15548627.2019.1643185. https://pubmed.ncbi.nlm.nih.gov/31339428/

7. Wu, Qi, Wang, Zhihong, Chen, Siqi, Wang, Guihua, Hu, Junbo. 2024. USP26 promotes colorectal cancer tumorigenesis by restraining PRKN-mediated mitophagy. In Oncogene, 43, 1581-1593. doi:10.1038/s41388-024-03009-0. https://pubmed.ncbi.nlm.nih.gov/38565942/

8. Xian, Hongxu, Liou, Yih-Cherng. 2019. Loss of MIEF1/MiD51 confers susceptibility to BAX-mediated cell death and PINK1-PRKN-dependent mitophagy. In Autophagy, 15, 2107-2125. doi:10.1080/15548627.2019.1596494. https://pubmed.ncbi.nlm.nih.gov/30894073/

9. Xiong, Zhenchong, Yang, Lin, Zhang, Chao, Song, Libing, Wang, Xi. 2024. MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation. In Autophagy, 21, 80-101. doi:10.1080/15548627.2024.2392415. https://pubmed.ncbi.nlm.nih.gov/39147386/

Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0338
Email:
animal-service@cyagen.com
service@cyagen.us
CRO Services
OncologyOphthalmologyNeuroscienceMetabolic & CardiovascularAutoimmune & InflammatoryGene TherapyAntibody Therapy
About Us
Corporate OverviewOur PartnersCareersContact Us
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest